Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.54 USD | +2.42% | -3.42% | +19.25% |
May. 21 | Erasca Closes Oversubscribed Share Offering to Raise $184 Million | MT |
May. 17 | Erasca Acquires 2 Exclusive Worldwide Licenses for Preclinical RAS Programs | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 687M |
---|---|---|---|---|---|
Net income 2024 * | -150M | Net income 2025 * | -168M | EV / Sales 2024 * | - |
Net cash position 2024 * | 315M | Net cash position 2025 * | 202M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.15
x | P/E ratio 2025 * |
-3.1
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.19% |
Latest transcript on Erasca, Inc.
1 day | +2.42% | ||
1 week | -3.42% | ||
Current month | +0.79% | ||
1 month | +21.53% | ||
3 months | -0.39% | ||
6 months | +52.10% | ||
Current year | +19.25% |
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Lim
CEO | Chief Executive Officer | 52 | 18-09-30 |
David Chacko
DFI | Director of Finance/CFO | 41 | 19-07-31 |
Chief Tech/Sci/R&D Officer | - | 22-05-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jean Liu
BRD | Director/Board Member | 55 | 22-04-24 |
Jonathan Lim
CEO | Chief Executive Officer | 52 | 18-09-30 |
Alexander Casdin
BRD | Director/Board Member | 56 | 18-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.52 | +1.61% | 1,822,228 |
24-05-30 | 2.48 | +2.90% | 1,553,291 |
24-05-29 | 2.41 | -4.37% | 7,998,604 |
24-05-28 | 2.52 | -4.18% | 2,039,010 |
24-05-24 | 2.63 | +1.54% | 2,927,939 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.25% | 687M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- ERAS Stock